EPIDEMIOLOGY OF MULTIPLE SCLEROSIS IN TURKEY, EAST MEDITERANEAN AND NEAR EAST AREA
Main Article Content
Abstract
Today, Multiple Sclerosis (MS) is one of the leading non-traumatic causes of permanent neurological disability in young and middle-aged populations. A 2020 statistical survey figures show that it affects 2.8 million people worldwide. This figure corresponds to an average of 1/3000 people, which figure is likely to rise further. Globally, the median estimated prevalence of MS is approximately 36 per 100,000 according to the international data, with 2.9 million people living with MS in the World in 2023. Regionally, the estimated median prevalence of MS is highest in Europe and the Americas. Regional differences in incidence generally run parallel to prevalence. A median prevalence and incidence was reported for Eastern Mediterranean area and Middle East but in the last decades this has tended to change. Also the incidence has increased in Mediterranean islands, but not all. Its prevalence increased from 40 per 100,000 to 100 per 100,000 in Turkey while in Greece, Cyprus, Basra Gulf and Middle East in general, a similarly increasing trend was observed in the recent years. The highest prevalence rates were reported in Iran (148.06 per 100,000) and higher incidence rates were estimated at 6.88 per 100,000 population in Kuwait. The same inceasing can be seen in some parts of Russia and Western Asia. In fact, the increasing trend in incidence can be seen even in the Far East, in China and Japan, where the prevalence and incidence were originally low. The gender distribution of MS in the region is also tending to change in the recent years, with more females having MS. Of the various risk factors cited for multiple sclerosis, especially migration seems to an important risk factor for the region, although there are some exceptions.
Article Details
How to Cite
TOGROL, RİFAT ERDEM.
EPIDEMIOLOGY OF MULTIPLE SCLEROSIS IN TURKEY, EAST MEDITERANEAN AND NEAR EAST AREA.
Medical Research Archives, [S.l.], v. 11, n. 11, nov. 2023.
ISSN 2375-1924.
Available at: <https://esmed.org/MRA/mra/article/view/4668>. Date accessed: 16 may 2024.
doi: https://doi.org/10.18103/mra.v11i11.4668.
Section
Research Articles
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
1. The Multiple Sclerosis International Federation Atlas of MS, 3rd ed, September, 2020
https://www.atlasofms.org
(Accessed 31 August 2023)
2. The Multiple Sclerosis International Federation Atlas of MS, 3rd ed, September, 2020: Mapping Multiple Sclerosis Around The World. Key Epidemiology Findings. Multiple Sclerosis International Federation, 2020.
www.msif.org/wp-content/uploads/2020/10/Atlas-3rd-Edition-Epidemiology-report-EN-updated-30-9-20.pdf
(Accessed 31 August 2023)
3. Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, Robertson N, La Rocca N, Uitdehaag B, van der Mei I, Wallin M, Helme A, Angood Napier C, Rijke N, Baneke P. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler. 2020 Dec;26(14):1816-1821.
4. Houzen H, Niino M, Kikuchi S, Fukazawa T, Nogoshi S, Matsumoto H, Tashiro K. The prevalence and clinical characteristics of MS in northern Japan. J Neurol Sci. 2003 Jul 15;211(1-2):49-53.
5. Houzen H, Kondo K, Horiuchi K, Niino M. Consistent increase in the prevalence and female ratio of multiple sclerosis over 15 years in northern Japan. Eur J Neurol. 2018 Feb;25(2):334-339.
6. Houzen H, Kano T, Kondo K, Takahashi T, Niino M. The prevalence and incidence of multiple sclerosis over the past 20 years in northern Japan. Mult Scler Relat Disord. 2023 May;73:104696.
7. Zhang GX, Carrillo-Vico A, Zhang WT, Gao SS, Izquierdo Ayuso G. Incidence and prevalence of multiple sclerosis in China and other Asian countries. Neurologia (Engl Ed). 2020 Oct 14:S0213-4853(20)30269-3. English, Spanish.
8. Koch-Henriksen N, Magyari M. Apparent changes in the epidemiology and severity of multiple sclerosis. Nat Rev Neurol. 2021 Nov;17(11):676-688
9. Lane J, Ng HS, Poyser C, Lucas RM, Tremlett H. Multiple sclerosis incidence: A systematic review of change over time by geographical region. Mult Scler Relat Disord. 2022 Jul;63:103932.
10. Koch-Henriksen N, Sørensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010 May;9(5):520-32.
11. Grimaldi LM, Salemi G, Grimaldi G, Rizzo A, Marziolo R, Lo Presti C, Maimone D, Savettieri G. High incidence and increasing prevalence of MS in Enna (Sicily), southern Italy. Neurology. 2001 Nov 27;57(10):1891-3.
12. Lauer K. Multiple sclerosis (MS) in the neighbouring islands of Sardinia, Italy, and Corsica, France. Clin Med Invest. 2018; 3(3): 1-2
13. Charalambidou E, Pantzaris M, Patrikios I. Multiple sclerosisin Cyprus: a fourteen year (2000–2014) epidemiological study. Am J Epidemiol Infect Dis. 2016;4(1):1–9
14. Usar S.(9 June 2023): KKTC’de MS’in epidemiyolojisi, tanı ve tedavi imkanları. Talk presented at: 5. Uluslararası Türk Dünyası Multipl Skleroz Kongresi, 8-11 June 2023, Bakı, Azerbaijan
https://www.mskongresi.org/program/
(Accessed: 20 September 2023
15. Vassallo L, Elian M, Dean G. Multiple sclerosis in southern Europe. II: Prevalence in Malta in 1978. J Epidemiol Community Health. 1979 Jun;33(2):111-3
16. Dean G, Elian M, de Bono AG, et al. Multiple sclerosis in Malta in 1999: an update. J Neurol Neurosurg Psychiatry. 2002 Sep;73(3):256-60.
17. Zalloua PA, Platt DE, El Sibai M et al.; Genographic Consortium. Identifying genetic traces of historical expansions: Phoenician footprints in the Mediterranean. Am J Hum Genet. 2008 Nov;83(5):633-42.
18. Mastorodemos V, Nikolakaki H, Tzagournissakis M et al. Benign multiple sclerosis in Crete. Mult Scler. 2010 Jun;16(6):701-6.
19. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci. 2001 Apr;22(2):117-39.
20. Çelik Y, Birgili Ö, Kiyat A et al. Prevalence of Multiple Sclerosis in the Metropolitan Area of Edirne City, Turkey. Balkan Med. Journal, 2011(2);193-6
21. Siva A., Uyanık Ö., Saip S. et al.(5-11 November 2005): Prevalence rate of Multiple Sclerosis in the Jewish community in İstanbul. Talk presented in World Congress of Neurology, 5-11 November 2005, Sydney, Australia. Proceedings 0591.
22. Türk Börü U, Alp R, Sur H, Gül L. Prevalence of multiple sclerosis door-to-door survey in Maltepe, Istanbul, Turkey. Neuroepidemiology. 2006;27(1):17-21.
23. Türk Börü Ü, Taşdemir M, Güler N et al. Prevalence of multiple sclerosis: door-to-door survey in three rural areas of coastal Black Sea regions of Turkey. Neuroepidemiology. 2011;37(3-4):231-5.
24. Akdemir N, Terzi M, Arslan N, Onar M. Prevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients. Arch.Neuropsych./ Noro Psikiyatr Ars.. 2017 Mar;54(1):11-14.
25. Alp R, Alp Sİ,Plancı Y,Yapıcı Z,Börü Ü. The prevalence of multiple sclerosis in the north caucasus region of Turkey: Door-to-Door Epidemiological Field Study; Arch.Neuropsych./ Noro Psikiyatr Arş.. 2012; 49(4): 272 - 275.
26. Türk Börü Ü, Duman A, Kulualp AŞ, Güler N, Taşdemir M. Multiple sclerosis prevalence study: The comparison of two coastal cities, located in the Black Sea and the Mediterranean Sea in Turkey. Journal of the Neurological Sciences; MS & Demyelinating Dis. 2013 Oct 15; 333 Suppl 1: E389
27. Türk Börü Ü, Duman A, Kulualp AŞ et al. Multiple sclerosis prevalence study: The comparison of 3 coastal cities, located in the black sea and mediterranean regions of Turkey. Medicine (Baltimore). 2018 Oct;97(42):e12856.
28. Bölük C, Türk Börü Ü, Taşdemir M, Gezer T. Epidemiology of Multiple Sclerosis in Turkey; A Ten-Year Trend in Rural Cities. Turk J Neurol. 2021; 27(1): 41-45.
29. Demir S, Tütüncü M, Uzunköprü C et al. A comprehensive assessment of patient experience and disease-related awareness in multiple sclerosis: A questionnaire-based nation-wide survey in Turkey. Mult Scler Relat Disord. 2021 Jul;52:103005.
30. Papathanasopoulos P, Gourzoulidou E, Messinis L, Georgiou V, Leotsinidis M. Prevalence and incidence of multiple sclerosis in western Greece: a 23-year survey. Neuroepidemiology. 2008;30(3):167-73.
31. Bakirtzis C, Grigoriadou E, Boziki MK et al. The Administrative Prevalence of Multiple Sclerosis in Greece on the Basis of a Nationwide Prescription Database. Front Neurol. 2020 Sep 29;11:1012.
32. Middleton LT, Dean G. Multiple sclerosis in Cyprus. J Neurol Sci. 1991 May;103(1):29-36.
33. Dean G, Aksoy H, Akalin T, Middleton L, Kyriallis K. Multiple sclerosis in the Turkish- and Greek-speaking communities of Cyprus. A United Nations (UNHCR) Bicommunal Project. J Neurol Sci. 1997 Feb 12;145(2):163-8.
34. Milanov I, Topalov N, Kmetski T. Prevalence of multiple sclerosis in Gypsies and Bulgarians. Neuroepidemiology. 1999;18(4):218-22.
35. Marcoci C, Lisnic V, Gavriliuc M, et al. Prevalence of Multiple Sclerosis in the Republic of Moldova. Neuroepidemiology. 2016;46(3):166-72.
36. European MSP. 2020 MS Barometer. Brussels: EMSP. Updated March 2021. Available from:
https://www.emsp.org/wp-content/uploads/2021/03/MS-Barometer2020-Final-Full-Report-Web.pdf
and from:
https://msbarometer.eu/2020
(Accessed 25 September 2023)
37. Klupka-Sarić I, Ristić S, Sepcić J et al. Epidemiology of multiple sclerosis in western Herzegovina. Clin Neurol Neurosurg. 2007 Nov;109(9):779-83.
38. Klupka-Sarić I, Galić M. Epidemiology of Multiple Sclerosis in Western Herzegovina and Herzegovina--Neretva Canton, Bosnia and Herzegovina. Coll Antropol. 2010 Mar;34 Suppl 1:189-93.
39. Benjak T, Štefančić V, Draušnik Ž, et al. Prevalence of multiple sclerosis in Croatia: data from national and non-governmental organization registries. Croat Med J. 2018 Apr 30;59(2):65-70.
40. Zeqiraj K, Kruja J, Kabashi S, Muçaj S. Epidemiological Characteristics and Functional Disability of Multiple Sclerosis Patients in Kosovo. Med Arch. 2014 Jun;68(3):178-81.
41. Boyko A, Melnikov M. Prevalence and Incidence of Multiple Sclerosis in Russian Federation: 30 Years of Studies. Brain Sci. 2020 May 18;10(5):305.
42. Djaparaliyeva N. (16 February 2019): Ülkelere göre MS fenotipi ve prevalansı: Kırgızistan. Talk presented at: Uluslararası Türk Dünyası Multipl Skleroz Kongresi/Congress. 14 – 17 February 2019, Gülhane Halil Akçiçek Konferans Salonu, Ankara-Turkey.
Available at:
https://www.mskongresi.org/kongre-sunumlari
(Accessed 20 September 2023)
43. Gafurov B. (16 February 2019) Ülkelere göre MS fenotipi ve prevalansı: Özbekistan. Talk presented at: Uluslararası Türk Dünyası Multipl Skleroz Kongresi/Congress. 14 - 17 February 2019, Gülhane Halil Akçiçek Konferans Salonu, Ankara-Turkey, Available at:
https://www.mskongresi.org/kongre-sunumlari/
(Accessed: 20 September 2023).
44. Muradov E. (16 February 2019) Ülkelere göre MS fenotipi ve prevalansı: Azerbaycan. (Azərbaycanda Dağınıq Skleroz (MS) Xəstəliyi, Klinik və Rast Gəlinmə Xüsusiyyetleri) Talk presented at: Uluslararası Türk Dünyası Multipl Skleroz Kongresi/Congress. 14 - 17 February 2019, Gülhane Halil Akçiçek Konferans Salonu, Ankara-Turkey. Available at:
https://www.mskongresi.org/kongre-sunumlari/
(Last accessed 26 September 2023
45. Hosseinzadeh A, Baneshi MR, Sedighi B, Kermanchi J, Haghdoost AA. Incidence of multiple sclerosis in Iran: a nationwide, population-based study. Public Health. 2019 Oct;175:138-144.
46. Sarmadi M, Saravani H, Azizi O, et al. Temporal trends of incidence and prevalence of multiple sclerosis in Razavi Khorasan Province, Northeast Iran. Neurol Sci. 2022 Jan;43(1):583-591.
47. Tolou-Ghamari, Z. A review of geoepidemiological differences of multiple sclerosis in Iran and other Middle East countries. Archives of neuroscience, 2015, 2(3): e22028 .
48. AlJumah M, Bunyan R, Al Otaibi H, et al. Rising prevalence of multiple sclerosis in Saudi Arabia, a descriptive study. BMC Neurol. 2020 Feb 8;20(1):49.
49. Al-Senani M, Al-Salti A, Nandhagopal R, et al. Epidemiology of multiple sclerosis in the Sultanate of Oman: A hospital based study. Mult Scler Relat Disord. 2021 Aug;53:103034.
50. Zeineddine M, Hajje AA, Hussein A, El Ayoubi N, Yamout B. Epidemiology of multiple sclerosis in Lebanon: A rising prevalence in the middle east. Mult Scler Relat Disord. 2021 Jul;52:102963.
51. Abuawad M, Ziyadeh-Isleem A, Alkaiyat A, et al. Epidemiology of multiple sclerosis in West bank of Palestine. Mult Scler Relat Disord. 2022 Mar; 59: 103686.
52. Hassoun HK, Al-Mahadawi A, Sheaheed NM, Sami SM, Jamal A, Allebban Z. Epidemiology of multiple sclerosis in Iraq: retrospective review of 4355 cases and literature review. Neurol Res. 2022 Jan;44(1):14-23.
53. Deleu D, Mir D, Al Tabouki A, et al. Prevalence, demographics and clinical characteristics of multiple sclerosis in Qatar. Mult Scler. 2013 May;19(6):816-9.
54. Inshasi J, Thakre M. Prevalence of multiple sclerosis in Dubai, United Arab Emirates. Int J Neurosci. 2011 Jul;121(7):393-8.
55. Alroughani R, Ahmed SF, Al-Hashel J. Demographics and clinical characteristics of multiple sclerosis in Kuwait. Eur Neurol. 2014;72(3-4):181-5.
56. Idris MN, Sokrab TE, Ibrahim EA, et al. Multiple sclerosis in Sudan: a prospective study of clinical presentation and outcome. Mult Scler. 2009 Dec;15(12):1537-8.
57. Öztürk Z, Yılmaz Ü, Konuşkan B, Gücüyener K, Demir E, Anlar B; Turkish Pediatric Multiple Sclerosis Study Group. Multiple Sclerosis with Onset Younger Than 10 Years in Turkey. Neuropediatrics. 2018 Feb;49(1):51-58.
58. Yılmaz Ü, Anlar B, Gücüyener K; Turkish Pediatric Multiple Sclerosis Study Group. Characteristics of pediatric multiple sclerosis: The Turkish pediatric multiple sclerosis database. Eur J Paediatr Neurol. 2017 Nov;21(6):864-872.
59. Dadouli K, Ntellas P, Anagnostopoulos L, Bonotis K, Dardiotis E, Hadjichristodoulou C. Geography of hospital admissions for multiple sclerosis in Greece. Mult Scler Relat Disord. 2021 Apr;49:102735.
60. Kantarci O, Siva A, Eraksoy M, et al.; Turkish Multiple Sclerosis Study Group (TUMSSG). Survival and predictors of disability in Turkish MS patients. Neurology. 1998 Sep;51(3):765-72.
61. Ramphul K, Lohana P, Verma R, Kumar N, Ramphul Y, Lohana A, Sombans S, Mejias SG, Kumari K, Joynauth J. An epidemiological analysis of multiple sclerosis patients hospitalized in the United States. Mult Scler Relat Disord. 2022 Jul;63:103840.
62. Yamout B, Barada W, Tohme RA, Mehio-Sibai A, Khalifeh R, El-Hajj T. Clinical characteristics of multiple sclerosis in Lebanon. J Neurol Sci. 2008 Jul 15;270(1-2):88-93.
63. Eskandarieh S, Sahraian M A. Epidemiological Evidence of the Recent Surge in MS in Asia and Australia: A Systematic Review. J Kermanshah Univ Med Sci. 2021;25(2):e111028
64. Trojano M, Lucchese G, Graziano G, et al.; MSBase Study Group and the New Zealand MS Prevalence Study Group. Geographical variations in sex ratio trends over time in multiple sclerosis. PLoS One. 2012;7(10):e48078.
65. Chitnis T. Role of puberty in multiple sclerosis risk and course. Clin Immunol. 2013 Nov;149(2):192-200.
66. Degelman ML, Herman KM. Smoking and multiple sclerosis: A systematic review and meta-analysis using the Bradford Hill criteria for causation. Mult Scler Relat Disord. 2017 Oct;17:207-216.
67. Weinshenker BG. Epidemiology of multiple sclerosis. Neurol Clin. 1996 May;14(2):291-308.
68. Alter M, Leibowitz U, Speer J. Risk of multiple sclerosis-related to age at immigration to Israel. Arch Neurol. 1966 Sep;15(3):234-7.
69. Alter M, Kahana E, Zilber N, Miller A. Multiple sclerosis frequency in Israel's diverse populations. Neurology. 2006 Apr 11;66(7):1061-6.
70. Nasr Z, Majed M, Rostami A, et al. Prevalence of multiple sclerosis in Iranian emigrants: review of the evidence. Neurol Sci. 2016 Nov;37(11):1759-1763.
71. Dean G, Wadia NH. Multiple sclerosis in the Parsis. J Neurol Neurosurg Psychiatry. 1995 Feb;58(2):254.
72. Wadia NH, Bhatia K. Multiple sclerosis is prevalent in the Zoroastrians (Parsis) of India. Ann Neurol. 1990 Aug;28(2):177-9
73. Naser Moghadasi A. Multiple sclerosis in parsis: a historical issue. Iran J Public Health. 2014 Mar;43(3):387-8.
74. Togrol E. (9 June 2023) Türkiye’de MS’in epidemiyolojisi, tanı ve tedavi imkanları. Talk presented at: 5. Uluslararası Türk Dünyası Multipl Skleroz Kongresi. 8-11 Haziran/ 8-11 June 2023, Bakı, Azerbaijan
https://www.mskongresi.org/program/
(Accessed: 12 September 2023).
https://www.atlasofms.org
(Accessed 31 August 2023)
2. The Multiple Sclerosis International Federation Atlas of MS, 3rd ed, September, 2020: Mapping Multiple Sclerosis Around The World. Key Epidemiology Findings. Multiple Sclerosis International Federation, 2020.
www.msif.org/wp-content/uploads/2020/10/Atlas-3rd-Edition-Epidemiology-report-EN-updated-30-9-20.pdf
(Accessed 31 August 2023)
3. Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, Robertson N, La Rocca N, Uitdehaag B, van der Mei I, Wallin M, Helme A, Angood Napier C, Rijke N, Baneke P. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler. 2020 Dec;26(14):1816-1821.
4. Houzen H, Niino M, Kikuchi S, Fukazawa T, Nogoshi S, Matsumoto H, Tashiro K. The prevalence and clinical characteristics of MS in northern Japan. J Neurol Sci. 2003 Jul 15;211(1-2):49-53.
5. Houzen H, Kondo K, Horiuchi K, Niino M. Consistent increase in the prevalence and female ratio of multiple sclerosis over 15 years in northern Japan. Eur J Neurol. 2018 Feb;25(2):334-339.
6. Houzen H, Kano T, Kondo K, Takahashi T, Niino M. The prevalence and incidence of multiple sclerosis over the past 20 years in northern Japan. Mult Scler Relat Disord. 2023 May;73:104696.
7. Zhang GX, Carrillo-Vico A, Zhang WT, Gao SS, Izquierdo Ayuso G. Incidence and prevalence of multiple sclerosis in China and other Asian countries. Neurologia (Engl Ed). 2020 Oct 14:S0213-4853(20)30269-3. English, Spanish.
8. Koch-Henriksen N, Magyari M. Apparent changes in the epidemiology and severity of multiple sclerosis. Nat Rev Neurol. 2021 Nov;17(11):676-688
9. Lane J, Ng HS, Poyser C, Lucas RM, Tremlett H. Multiple sclerosis incidence: A systematic review of change over time by geographical region. Mult Scler Relat Disord. 2022 Jul;63:103932.
10. Koch-Henriksen N, Sørensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010 May;9(5):520-32.
11. Grimaldi LM, Salemi G, Grimaldi G, Rizzo A, Marziolo R, Lo Presti C, Maimone D, Savettieri G. High incidence and increasing prevalence of MS in Enna (Sicily), southern Italy. Neurology. 2001 Nov 27;57(10):1891-3.
12. Lauer K. Multiple sclerosis (MS) in the neighbouring islands of Sardinia, Italy, and Corsica, France. Clin Med Invest. 2018; 3(3): 1-2
13. Charalambidou E, Pantzaris M, Patrikios I. Multiple sclerosisin Cyprus: a fourteen year (2000–2014) epidemiological study. Am J Epidemiol Infect Dis. 2016;4(1):1–9
14. Usar S.(9 June 2023): KKTC’de MS’in epidemiyolojisi, tanı ve tedavi imkanları. Talk presented at: 5. Uluslararası Türk Dünyası Multipl Skleroz Kongresi, 8-11 June 2023, Bakı, Azerbaijan
https://www.mskongresi.org/program/
(Accessed: 20 September 2023
15. Vassallo L, Elian M, Dean G. Multiple sclerosis in southern Europe. II: Prevalence in Malta in 1978. J Epidemiol Community Health. 1979 Jun;33(2):111-3
16. Dean G, Elian M, de Bono AG, et al. Multiple sclerosis in Malta in 1999: an update. J Neurol Neurosurg Psychiatry. 2002 Sep;73(3):256-60.
17. Zalloua PA, Platt DE, El Sibai M et al.; Genographic Consortium. Identifying genetic traces of historical expansions: Phoenician footprints in the Mediterranean. Am J Hum Genet. 2008 Nov;83(5):633-42.
18. Mastorodemos V, Nikolakaki H, Tzagournissakis M et al. Benign multiple sclerosis in Crete. Mult Scler. 2010 Jun;16(6):701-6.
19. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci. 2001 Apr;22(2):117-39.
20. Çelik Y, Birgili Ö, Kiyat A et al. Prevalence of Multiple Sclerosis in the Metropolitan Area of Edirne City, Turkey. Balkan Med. Journal, 2011(2);193-6
21. Siva A., Uyanık Ö., Saip S. et al.(5-11 November 2005): Prevalence rate of Multiple Sclerosis in the Jewish community in İstanbul. Talk presented in World Congress of Neurology, 5-11 November 2005, Sydney, Australia. Proceedings 0591.
22. Türk Börü U, Alp R, Sur H, Gül L. Prevalence of multiple sclerosis door-to-door survey in Maltepe, Istanbul, Turkey. Neuroepidemiology. 2006;27(1):17-21.
23. Türk Börü Ü, Taşdemir M, Güler N et al. Prevalence of multiple sclerosis: door-to-door survey in three rural areas of coastal Black Sea regions of Turkey. Neuroepidemiology. 2011;37(3-4):231-5.
24. Akdemir N, Terzi M, Arslan N, Onar M. Prevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients. Arch.Neuropsych./ Noro Psikiyatr Ars.. 2017 Mar;54(1):11-14.
25. Alp R, Alp Sİ,Plancı Y,Yapıcı Z,Börü Ü. The prevalence of multiple sclerosis in the north caucasus region of Turkey: Door-to-Door Epidemiological Field Study; Arch.Neuropsych./ Noro Psikiyatr Arş.. 2012; 49(4): 272 - 275.
26. Türk Börü Ü, Duman A, Kulualp AŞ, Güler N, Taşdemir M. Multiple sclerosis prevalence study: The comparison of two coastal cities, located in the Black Sea and the Mediterranean Sea in Turkey. Journal of the Neurological Sciences; MS & Demyelinating Dis. 2013 Oct 15; 333 Suppl 1: E389
27. Türk Börü Ü, Duman A, Kulualp AŞ et al. Multiple sclerosis prevalence study: The comparison of 3 coastal cities, located in the black sea and mediterranean regions of Turkey. Medicine (Baltimore). 2018 Oct;97(42):e12856.
28. Bölük C, Türk Börü Ü, Taşdemir M, Gezer T. Epidemiology of Multiple Sclerosis in Turkey; A Ten-Year Trend in Rural Cities. Turk J Neurol. 2021; 27(1): 41-45.
29. Demir S, Tütüncü M, Uzunköprü C et al. A comprehensive assessment of patient experience and disease-related awareness in multiple sclerosis: A questionnaire-based nation-wide survey in Turkey. Mult Scler Relat Disord. 2021 Jul;52:103005.
30. Papathanasopoulos P, Gourzoulidou E, Messinis L, Georgiou V, Leotsinidis M. Prevalence and incidence of multiple sclerosis in western Greece: a 23-year survey. Neuroepidemiology. 2008;30(3):167-73.
31. Bakirtzis C, Grigoriadou E, Boziki MK et al. The Administrative Prevalence of Multiple Sclerosis in Greece on the Basis of a Nationwide Prescription Database. Front Neurol. 2020 Sep 29;11:1012.
32. Middleton LT, Dean G. Multiple sclerosis in Cyprus. J Neurol Sci. 1991 May;103(1):29-36.
33. Dean G, Aksoy H, Akalin T, Middleton L, Kyriallis K. Multiple sclerosis in the Turkish- and Greek-speaking communities of Cyprus. A United Nations (UNHCR) Bicommunal Project. J Neurol Sci. 1997 Feb 12;145(2):163-8.
34. Milanov I, Topalov N, Kmetski T. Prevalence of multiple sclerosis in Gypsies and Bulgarians. Neuroepidemiology. 1999;18(4):218-22.
35. Marcoci C, Lisnic V, Gavriliuc M, et al. Prevalence of Multiple Sclerosis in the Republic of Moldova. Neuroepidemiology. 2016;46(3):166-72.
36. European MSP. 2020 MS Barometer. Brussels: EMSP. Updated March 2021. Available from:
https://www.emsp.org/wp-content/uploads/2021/03/MS-Barometer2020-Final-Full-Report-Web.pdf
and from:
https://msbarometer.eu/2020
(Accessed 25 September 2023)
37. Klupka-Sarić I, Ristić S, Sepcić J et al. Epidemiology of multiple sclerosis in western Herzegovina. Clin Neurol Neurosurg. 2007 Nov;109(9):779-83.
38. Klupka-Sarić I, Galić M. Epidemiology of Multiple Sclerosis in Western Herzegovina and Herzegovina--Neretva Canton, Bosnia and Herzegovina. Coll Antropol. 2010 Mar;34 Suppl 1:189-93.
39. Benjak T, Štefančić V, Draušnik Ž, et al. Prevalence of multiple sclerosis in Croatia: data from national and non-governmental organization registries. Croat Med J. 2018 Apr 30;59(2):65-70.
40. Zeqiraj K, Kruja J, Kabashi S, Muçaj S. Epidemiological Characteristics and Functional Disability of Multiple Sclerosis Patients in Kosovo. Med Arch. 2014 Jun;68(3):178-81.
41. Boyko A, Melnikov M. Prevalence and Incidence of Multiple Sclerosis in Russian Federation: 30 Years of Studies. Brain Sci. 2020 May 18;10(5):305.
42. Djaparaliyeva N. (16 February 2019): Ülkelere göre MS fenotipi ve prevalansı: Kırgızistan. Talk presented at: Uluslararası Türk Dünyası Multipl Skleroz Kongresi/Congress. 14 – 17 February 2019, Gülhane Halil Akçiçek Konferans Salonu, Ankara-Turkey.
Available at:
https://www.mskongresi.org/kongre-sunumlari
(Accessed 20 September 2023)
43. Gafurov B. (16 February 2019) Ülkelere göre MS fenotipi ve prevalansı: Özbekistan. Talk presented at: Uluslararası Türk Dünyası Multipl Skleroz Kongresi/Congress. 14 - 17 February 2019, Gülhane Halil Akçiçek Konferans Salonu, Ankara-Turkey, Available at:
https://www.mskongresi.org/kongre-sunumlari/
(Accessed: 20 September 2023).
44. Muradov E. (16 February 2019) Ülkelere göre MS fenotipi ve prevalansı: Azerbaycan. (Azərbaycanda Dağınıq Skleroz (MS) Xəstəliyi, Klinik və Rast Gəlinmə Xüsusiyyetleri) Talk presented at: Uluslararası Türk Dünyası Multipl Skleroz Kongresi/Congress. 14 - 17 February 2019, Gülhane Halil Akçiçek Konferans Salonu, Ankara-Turkey. Available at:
https://www.mskongresi.org/kongre-sunumlari/
(Last accessed 26 September 2023
45. Hosseinzadeh A, Baneshi MR, Sedighi B, Kermanchi J, Haghdoost AA. Incidence of multiple sclerosis in Iran: a nationwide, population-based study. Public Health. 2019 Oct;175:138-144.
46. Sarmadi M, Saravani H, Azizi O, et al. Temporal trends of incidence and prevalence of multiple sclerosis in Razavi Khorasan Province, Northeast Iran. Neurol Sci. 2022 Jan;43(1):583-591.
47. Tolou-Ghamari, Z. A review of geoepidemiological differences of multiple sclerosis in Iran and other Middle East countries. Archives of neuroscience, 2015, 2(3): e22028 .
48. AlJumah M, Bunyan R, Al Otaibi H, et al. Rising prevalence of multiple sclerosis in Saudi Arabia, a descriptive study. BMC Neurol. 2020 Feb 8;20(1):49.
49. Al-Senani M, Al-Salti A, Nandhagopal R, et al. Epidemiology of multiple sclerosis in the Sultanate of Oman: A hospital based study. Mult Scler Relat Disord. 2021 Aug;53:103034.
50. Zeineddine M, Hajje AA, Hussein A, El Ayoubi N, Yamout B. Epidemiology of multiple sclerosis in Lebanon: A rising prevalence in the middle east. Mult Scler Relat Disord. 2021 Jul;52:102963.
51. Abuawad M, Ziyadeh-Isleem A, Alkaiyat A, et al. Epidemiology of multiple sclerosis in West bank of Palestine. Mult Scler Relat Disord. 2022 Mar; 59: 103686.
52. Hassoun HK, Al-Mahadawi A, Sheaheed NM, Sami SM, Jamal A, Allebban Z. Epidemiology of multiple sclerosis in Iraq: retrospective review of 4355 cases and literature review. Neurol Res. 2022 Jan;44(1):14-23.
53. Deleu D, Mir D, Al Tabouki A, et al. Prevalence, demographics and clinical characteristics of multiple sclerosis in Qatar. Mult Scler. 2013 May;19(6):816-9.
54. Inshasi J, Thakre M. Prevalence of multiple sclerosis in Dubai, United Arab Emirates. Int J Neurosci. 2011 Jul;121(7):393-8.
55. Alroughani R, Ahmed SF, Al-Hashel J. Demographics and clinical characteristics of multiple sclerosis in Kuwait. Eur Neurol. 2014;72(3-4):181-5.
56. Idris MN, Sokrab TE, Ibrahim EA, et al. Multiple sclerosis in Sudan: a prospective study of clinical presentation and outcome. Mult Scler. 2009 Dec;15(12):1537-8.
57. Öztürk Z, Yılmaz Ü, Konuşkan B, Gücüyener K, Demir E, Anlar B; Turkish Pediatric Multiple Sclerosis Study Group. Multiple Sclerosis with Onset Younger Than 10 Years in Turkey. Neuropediatrics. 2018 Feb;49(1):51-58.
58. Yılmaz Ü, Anlar B, Gücüyener K; Turkish Pediatric Multiple Sclerosis Study Group. Characteristics of pediatric multiple sclerosis: The Turkish pediatric multiple sclerosis database. Eur J Paediatr Neurol. 2017 Nov;21(6):864-872.
59. Dadouli K, Ntellas P, Anagnostopoulos L, Bonotis K, Dardiotis E, Hadjichristodoulou C. Geography of hospital admissions for multiple sclerosis in Greece. Mult Scler Relat Disord. 2021 Apr;49:102735.
60. Kantarci O, Siva A, Eraksoy M, et al.; Turkish Multiple Sclerosis Study Group (TUMSSG). Survival and predictors of disability in Turkish MS patients. Neurology. 1998 Sep;51(3):765-72.
61. Ramphul K, Lohana P, Verma R, Kumar N, Ramphul Y, Lohana A, Sombans S, Mejias SG, Kumari K, Joynauth J. An epidemiological analysis of multiple sclerosis patients hospitalized in the United States. Mult Scler Relat Disord. 2022 Jul;63:103840.
62. Yamout B, Barada W, Tohme RA, Mehio-Sibai A, Khalifeh R, El-Hajj T. Clinical characteristics of multiple sclerosis in Lebanon. J Neurol Sci. 2008 Jul 15;270(1-2):88-93.
63. Eskandarieh S, Sahraian M A. Epidemiological Evidence of the Recent Surge in MS in Asia and Australia: A Systematic Review. J Kermanshah Univ Med Sci. 2021;25(2):e111028
64. Trojano M, Lucchese G, Graziano G, et al.; MSBase Study Group and the New Zealand MS Prevalence Study Group. Geographical variations in sex ratio trends over time in multiple sclerosis. PLoS One. 2012;7(10):e48078.
65. Chitnis T. Role of puberty in multiple sclerosis risk and course. Clin Immunol. 2013 Nov;149(2):192-200.
66. Degelman ML, Herman KM. Smoking and multiple sclerosis: A systematic review and meta-analysis using the Bradford Hill criteria for causation. Mult Scler Relat Disord. 2017 Oct;17:207-216.
67. Weinshenker BG. Epidemiology of multiple sclerosis. Neurol Clin. 1996 May;14(2):291-308.
68. Alter M, Leibowitz U, Speer J. Risk of multiple sclerosis-related to age at immigration to Israel. Arch Neurol. 1966 Sep;15(3):234-7.
69. Alter M, Kahana E, Zilber N, Miller A. Multiple sclerosis frequency in Israel's diverse populations. Neurology. 2006 Apr 11;66(7):1061-6.
70. Nasr Z, Majed M, Rostami A, et al. Prevalence of multiple sclerosis in Iranian emigrants: review of the evidence. Neurol Sci. 2016 Nov;37(11):1759-1763.
71. Dean G, Wadia NH. Multiple sclerosis in the Parsis. J Neurol Neurosurg Psychiatry. 1995 Feb;58(2):254.
72. Wadia NH, Bhatia K. Multiple sclerosis is prevalent in the Zoroastrians (Parsis) of India. Ann Neurol. 1990 Aug;28(2):177-9
73. Naser Moghadasi A. Multiple sclerosis in parsis: a historical issue. Iran J Public Health. 2014 Mar;43(3):387-8.
74. Togrol E. (9 June 2023) Türkiye’de MS’in epidemiyolojisi, tanı ve tedavi imkanları. Talk presented at: 5. Uluslararası Türk Dünyası Multipl Skleroz Kongresi. 8-11 Haziran/ 8-11 June 2023, Bakı, Azerbaijan
https://www.mskongresi.org/program/
(Accessed: 12 September 2023).